Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Neostigmine MeSH Descriptor Data 2026


MeSH Heading
Neostigmine
Tree Number(s)
D02.092.877.674.666
D02.675.276.602
Unique ID
D009388
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D009388
Scope Note
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
Entry Term(s)
Neostigmine Bromide
Neostigmine Methylsulfate
Polstigmine
Proserine
Prostigmin
Prostigmine
Prozerin
Synstigmin
Syntostigmine
Pharm Action
Cholinesterase Inhibitors
Parasympathomimetics
Registry Numbers
3982TWQ96G
98IMH7M386
0
005SYP50G5
Related Numbers
005SYP50G5
114-80-7
51-60-5
59-99-4
98IMH7M386
CAS Type 1 Name
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-
NLM Classification #
QV 124
Date Introduced
1966/01/01
Last Updated
2013/07/08
Neostigmine Preferred
Neostigmine Methylsulfate Narrower
Polstigmine Narrower
Syntostigmine Narrower
Prostigmine Narrower
Neostigmine Bromide Narrower
page delivered in 0.18s